Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1

Cell Cycle

Volumn 12, Issue 4, 2013, Pages 606-617

  Caldon, C Elizabeth ^a   Sergio, C Marcelo ^a   Burgess, Andrew ^a,b   Deans, Andrew J ^c   Sutherland, Robert L ^a,b   Musgrove, Elizabeth A ^a,b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Cyclin E1; Cyclin E2; Genomic instability; Mitosis; P107

Indexed keywords

BETA ACTIN; CYCLIN A; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; CYCLIN E1; CYCLIN E2; PROTEIN P107; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL CYCLE; CHROMOSOME ABERRATION; DNA SYNTHESIS; G2 PHASE CELL CYCLE CHECKPOINT; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; METAPHASE; MICRONUCLEUS; MITOSIS; PROTEIN BINDING;

EID: 84874613331     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.23512     Document Type: Article

References (57)

1. Hwang HC, Clurman BE. Cyclin E in normal and neoplastic cell cycles. Oncogene 2005; 24:2776-86; PMID:15838514; http://dx.doi.org/10.1038/sj.onc. 1208613
2. Juan G, Cordon-Cardo C. Intranuclear compartmentalization of cyclin E during the cell cycle: disruption of the nucleoplasm-nucleolar shuttling of cyclin E in bladder cancer. Cancer Res 2001; 61:1220-6; PMID:11221854
3. Bortner DM, Rosenberg MP. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol Cell Biol 1997; 17:453-9; PMID:8972226
4. Ma Y, Fiering S, Black C, Liu X, Yuan Z, Memoli VA, et al. Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas. Proc Natl Acad Sci U S A 2007; 104:4089-94; PMID:17360482; http://dx.doi. org/10.1073/pnas.0606537104
5. Loeb KR, Kostner H, Firpo E, Norwood T, D Tsuchiya K, Clurman BE, et al. A mouse model for cyclin E-dependent genetic instability and tumorigenesis. Cancer Cell 2005; 8:35-47; PMID:16023597; http://dx.doi.org/10.1016/j.ccr.2005. 06.010
6. (Kip1), polyploidy and centrosome overduplication. EMBO J 2000; 19:2069-81; PMID:10790373; http://dx.doi.org/10.1093/emboj/19.9.2069
7. (Cdh1). J Cell Biol 2007; 178:371-85; PMID:17664332; http://dx.doi.org/10.1083/jcb.200703202
8. Ekholm-Reed S, Méndez J, Tedesco D, Zetterberg A, Stillman B, Reed SI. Deregulation of cyclin E in human cells interferes with prereplication complex assembly. J Cell Biol 2004; 165:789-800; PMID:15197178; http://dx.doi.org/10.1083/jcb.200404092
9. Spruck CH, Won KA, Reed SI. Deregulated cyclin E induces chromosome instability. Nature 1999; 401:297-300; PMID:10499591; http://dx.doi. org/10.1038/45836
10. Akli S, Zheng PJ, Multani AS, Wingate HF, Pathak S, Zhang N, et al. Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer. Cancer Res 2004; 64:3198-208; PMID:15126360; http://dx.doi.org/10.1158/0008-5472.CAN-03- 3672
11. Fbw7 ubiquitin ligase. Science 2001; 294:173-7; PMID:11533444; http://dx.doi.org/10. 1126/science.1065203
12. Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 2008; 8:83-93; PMID:18094723; http://dx.doi.org/10.1038/nrc2290
13. Ekholm-Reed S, Spruck CH, Sangfelt O, van Drogen F, Mueller-Holzner E, Widschwendter M, et al. Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer. Cancer Res 2004; 64:795-800; PMID:14871801; http://dx.doi.org/10.1158/0008-5472.CAN-03-3417
14. Pascreau G, Churchill ME, Maller JL. Centrosomal localization of cyclins E and A: structural similarities and functional differences. Cell Cycle 2011; 10:199-205; PMID:21217199; http://dx.doi.org/10.4161/cc.10.2.14444
15. Geng Y, Yu Q, Sicinska E, Das M, Schneider JE, Bhattacharya S, et al. Cyclin E ablation in the mouse. Cell 2003; 114:431-43; PMID:12941272; http://dx.doi.org/10.1016/S0092-8674(03)00645-7
16. 1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers. Mol Cell Biol 1999; 19:612-22; PMID:9858585
17. 1 and S phases of the mammalian cell cycle. Oncogene 1998; 17:2637-43; PMID:9840927; http://dx.doi.org/10.1038/sj.onc.1202477
18. 1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins. Oncogene 1998; 17:2787-98; PMID:9840943; http://dx.doi. org/10.1038/sj.onc. 1202505
19. (Fbxw7/hCdc4) targets cyclin E2 for ubiquitindependent proteolysis. Exp Cell Res 2009; 315:1832-9; PMID:19084516; http://dx.doi.org/10.1016/j. yexcr.2008.11.017
20. Caldon CE, Musgrove EA. Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer. Cell Div 2010; 5:2; PMID:20180967; http://dx.doi.org/10.1186/1747-1028-5-2
21. Nevzorova YA, Tschaharganeh D, Gassler N, Geng Y, Weiskirchen R, Sicinski P, et al. Aberrant cell cycle progression and endoreplication in regenerating livers of mice that lack a single E-type cyclin. Gastroenterology 2009; 137:691-703, 703, e1-6; PMID:19445941; http://dx.doi.org/10.1053/j.gastro.2009. 05.003
22. Caldon CE, Sergio CM, Kang J, Muthukaruppan A, Boersma MN, Stone A, et al. Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells. Mol Cancer Ther 2012; 11:1488-99; PMID:22564725; http://dx.doi.org/10.1158/1535-7163.MCT-11-0963
23. Bagheri-Yarmand R, Biernacka A, Hunt KK, Keyomarsi K. Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification. Cancer Res 2010; 70:5074-84; PMID:20530685; http://dx.doi. org/10.1158/0008-5472.CAN-09-4094
24. Leontieva OV, Lenzo F, Demidenko ZN, Blagosklonny MV. Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells. Cell Cycle 2012; 11:4642-9; PMID:23187803; http://dx.doi. org/10.4161/cc.22937
25. Caldon CE, Swarbrick A, Lee CS, Sutherland RL, Musgrove EA. The helix-loop-helix protein Id1 requires cyclin D1 to promote the proliferation of mammary epithelial cell acini. Cancer Res 2008; 68:3026-36; PMID:18413773; http://dx.doi.org/10.1158/0008-5472.CAN-07-3079
26. Porter DC, Zhang N, Danes C, McGahren MJ, Harwell RM, Faruki S, et al. Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight forms. Mol Cell Biol 2001; 21:6254-69; PMID:11509668; http://dx.doi. org/10.1128/MCB.21.18.6254-6269.2001
27. 1 in mammalian fibroblasts. Science 1993; 259:1908-12; PMID:8384376; http://dx.doi. org/10.1126/science.8384376
28. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 1994; 14:1669-79; PMID:8114703
29. Chibazakura T, McGrew SG, Cooper JA, Yoshikawa H, Roberts JM. Regulation of cyclin-dependent kinase activity during mitotic exit and maintenance of genome stability by p21, p27, and p107. Proc Natl Acad Sci U S A 2004; 101:4465-70; PMID:15070741; http://dx.doi.org/10.1073/pnas.0400655101
30. Fbw7 cooperatively restrain cyclin E-associated genome instability. Oncogene 2007; 26:6948-53; PMID:17486057; http://dx.doi.org/10.1038/sj.onc.1210518
31. Minella AC, Swanger J, Bryant E, Welcker M, Hwang H, Clurman BE. p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation. Curr Biol 2002; 12:1817-27; PMID:12419181; http://dx.doi.org/10. 1016/S0960-9822(02)01225-3
32. Theodorou V, Kimm MA, Boer M, Wessels L, Theelen W, Jonkers J, et al. MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer. Nat Genet 2007; 39:759-69; PMID:17468756; http://dx.doi.org/10.1038/ng2034
33. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 2006; 98:262-72; PMID:16478745; http://dx.doi.org/10.1093/jnci/djj052
34. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415:530-6; PMID:11823860; http://dx.doi. org/10.1038/415530a
35. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005; 365:671-9; PMID:15721472
36. 2/M arrest in response to DNA damage, leading to an increase in genetic instability. Mol Cell Biol 2008; 28:258-68; PMID:17954563; http://dx.doi.org/10.1128/MCB.01536-07
37. Kolupaeva V, Basilico C. Overexpression of cyclin E/CDK2 complexes overcomes FGF-induced cell cycle arrest in the presence of hypophosphorylated Rb proteins. Cell Cycle 2012; 11:2557-66; PMID:22713240; http://dx.doi.org/10. 4161/cc.20944
38. Dhillon NK, Mudryj M. Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest. Oncogene 2002; 21:4626-34; PMID:12096339; http://dx.doi.org/10.1038/sj.onc.1205576
39. 1 cyclin-associated kinases. Proc Natl Acad Sci U S A 1996; 93:4633-7; PMID:8643455; http://dx.doi.org/10.1073/pnas.93.10.4633
40. van Harn T, Foijer F, van Vugt M, Banerjee R, Yang F, Oostra A, et al. Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling. Genes Dev 2010; 24:1377-88; PMID:20551164; http://dx.doi.org/10.1101/ gad.580710
41. Manning AL, Longworth MS, Dyson NJ. Loss of pRB causes centromere dysfunction and chromosomal instability. Genes Dev 2010; 24:1364-76; PMID:20551165; http://dx.doi.org/10.1101/gad.1917310
42. Coschi CH, Martens AL, Ritchie K, Francis SM, Chakrabarti S, Berube NG, et al. Mitotic chromosome condensation mediated by the retinoblastoma protein is tumor-suppressive. Genes Dev 2010; 24:1351-63; PMID:20551166; http://dx.doi.org/10.1101/gad.1917610
43. Alexandrow MG, Hamlin JL. Chromatin decondensation in S-phase involves recruitment of Cdk2 by Cdc45 and histone H1 phosphorylation. J Cell Biol 2005; 168:875-86; PMID:15753125; http://dx.doi. org/10.1083/jcb.200409055
44. Hall C, Nelson DM, Ye X, Baker K, DeCaprio JA, Seeholzer S, et al. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression. Mol Cell Biol 2001; 21:1854-65; PMID:11238922; http://dx.doi.org/10.1128/MCB.21.5.1854-1865.2001
45. Müller-Tidow C, Wang W, Idos GE, Diederichs S, Yang R, Readhead C, et al. Cyclin A1 directly interacts with B-myb and cyclin A1/cdk2 phosphorylate B-myb at functionally important serine and threonine residues: tissue-specific regulation of B-myb function. Blood 2001; 97:2091-7; PMID:11264176; http://dx.doi. org/10.1182/blood.V97.7.2091
46. Chi Y, Welcker M, Hizli AA, Posakony JJ, Aebersold R, Clurman BE. Identification of CDK2 substrates in human cell lysates. Genome Biol 2008; 9:R149; PMID:18847512; http://dx.doi.org/10.1186/gb-2008-9-10-r149
47. Lanzotti DJ, Kupsco JM, Marzluff WF, Duronio RJ. string(cdc25) and cyclin E are required for patterned histone expression at different stages of Drosophila embryonic development. Dev Biol 2004; 274:82-93; PMID:15355790; http://dx.doi.org/10.1016/j. ydbio.2004.06.019
48. Ma T, Van Tine BA, Wei Y, Garrett MD, Nelson D, Adams PD, et al. Cell cycle-regulated phosphorylation of p220(NPAT) by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription. Genes Dev 2000; 14:2298-313; PMID:10995387; http://dx.doi. org/10.1101/gad.829500
49. Wei Y, Yu L, Bowen J, Gorovsky MA, Allis CD. Phosphorylation of histone H3 is required for proper chromosome condensation and segregation. Cell 1999; 97:99-109; PMID:10199406; http://dx.doi. org/10.1016/S0092-8674(00)80718-7
50. Salzler HR, Davidson JM, Montgomery ND, Duronio RJ. Loss of the histone pre-mRNA processing factor stem-loop binding protein in Drosophila causes genomic instability and impaired cellular proliferation. PLoS One 2009; 4:e8168; PMID:19997601; http://dx.doi.org/10.1371/journal.pone.0008168
51. Bester AC, Roniger M, Oren YS, Im MM, Sarni D, Chaoat M, et al. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 2011; 145:435-46; PMID:21529715; http://dx.doi.org/10.1016/j. cell.2011.03.044
52. Geng Y, Yu Q, Whoriskey W, Dick F, Tsai KY, Ford HL, et al. Expression of cyclins E1 and E2 during mouse development and in neoplasia. Proc Natl Acad Sci U S A 2001; 98:13138-43; PMID:11687642; http://dx.doi.org/10.1073/pnas. 231487798
53. (Kip1) association with cyclin E-Cdk2. J Biol Chem 2001; 276:47675-83; PMID:11590147; http://dx.doi. org/10.1074/jbc.M106371200
54. Caldon CE, Sergio CM, Schütte J, Boersma MN, Sutherland RL, Carroll JS, et al. Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc. Mol Cell Biol 2009; 29:4623-39; PMID:19564413; http://dx.doi.org/10.1128/MCB. 00269-09
55. 2)-phase checkpoints after ionizing irradiation. Mol Cell Biol 2001; 21:3445-50; PMID:11313470; http://dx.doi.org/10.1128/MCB.21.10.3445-3450.2001
56. Prall OWJ, Rogan EM, Musgrove EA, Watts CKW, Sutherland RL. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry. Mol Cell Biol 1998; 18:4499-508; PMID:9671459
57. MacKay C, Déclais AC, Lundin C, Agostinho A, Deans AJ, MacArtney TJ, et al. Identification of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinated FANCD2. Cell 2010; 142:65-76; PMID:20603015; http://dx.doi. org/10.1016/j.cell.2010.06.021